Regulation of Differentiation, Proliferation and Drug-Induced Apoptosis in HT58 Lymphoma Cells
- PMID: 11173634
- DOI: 10.1007/BF02907802
Regulation of Differentiation, Proliferation and Drug-Induced Apoptosis in HT58 Lymphoma Cells
Abstract
Recently, it has been suggested, that differentiated cells are more resistant to the apoptotic effect of DNA damaging agents possibly due to the decreased activity of "damage detecting/apoptosis triggering" mechanism. Previously, we have shown, that PMA pretreatment reduced etoposide-(ETO) but enhanced staurosporine- (STA) -induced apoptosis in HT58 cells. Data presented here show that the HT58 human, "mature" B-lymphoma cells exposed to PMA secrete more IgM into the supernatant indicating commitment of cells to perform differentiated function. The sensitivity of HT58 cells to ETO- or STA-induced apoptosis is influenced diversely with PMA pre- or posttreatment. Interestingly, the DNA damage (gamma radiation, bleomycin, ETO) or okadaic acic (30 nM) reduced the [PMA+STA] induced apoptosis.
Similar articles
-
Modulation of drug-induced apoptosis in a human B-lymphoma cell line (HT58).Immunol Lett. 1995 Nov;48(1):17-21. doi: 10.1016/0165-2478(95)02434-4. Immunol Lett. 1995. PMID: 8847085
-
Modulation of apoptosis signaling in etoposide-treated lymphoma cells.Anticancer Res. 1997 Jul-Aug;17(4A):2609-14. Anticancer Res. 1997. PMID: 9252689
-
BCNU is a caspase-mediated inhibitor of drug-induced apoptosis.Cancer Res. 1998 Feb 15;58(4):614-8. Cancer Res. 1998. PMID: 9485009
-
Possible involvement of protein kinase C-epsilon in phorbol ester-induced growth inhibition of human lymphoblastic cells.Int J Biochem Cell Biol. 1996 Aug;28(8):925-33. doi: 10.1016/1357-2725(96)00020-9. Int J Biochem Cell Biol. 1996. PMID: 8811841
-
Effect of phorbol ester treatment on drug-induced, topoisomerase II-mediated DNA cleavage in human leukemia cells.Cancer Res. 1988 Dec 1;48(23):6625-33. Cancer Res. 1988. PMID: 2846155
References
LinkOut - more resources
Full Text Sources